Global Home Infusion Therapy Market
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Home Infusion Therapy Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis" report has been added to ResearchAndMarkets.com's offering. Global Home Infusion Therapy Market is expected to reach US$ 45.46 billion in 2027 from $27.97 billion in 2021, growing at a CAGR of 8.43%
Patients have shifted from conventional treatments to specialty infusion therapy treatments such as home infusion therapy over the years. Furthermore, the home infusion therapy industry is adept at meeting the most complex patient requirements. The demand for home infusion therapy devices will increase in the coming years as the application spectrum of infusion devices expands, along with the growing demand for infusion devices in the home care market. Furthermore, an aging population, a higher prevalence of chronic diseases, and the novelty of such therapeutic devices contribute to the overall market's growth. In contrast, associated risks during medication administration, irregularities in infusion device operation, incorrect use of infusion devices, and complex reimbursement policies may stifle market growth. Covid-19 Pandemic Boosted the Home Infusion Market Across the World
The Covid-19 pandemic had a favourable consequence on the home infusion market because the technique of home infusion was in high demand as healthcare facilities were overburdened with increasing numbers of Covid patients. Regional and national lockdowns significantly impacted operations and supply chains, yet the market grew substantially in 2020.
Product Insights Across Home Infusion Therapy Market Worldwide
By product, the home infusion therapy market is divided into four categories: infusion pumps, intravenous sets, IV cannulas, and needleless connectors. According to the analysis, the infusion pumps segment will have significant market because these pumps are widely used for the delivery of nutrients and medications. The availability of a wide range of products, including enteral, syringe, multichannel, and peristaltic pumps, contributes to segment growth.
The rising market for syringes and ambulatory pumps as people prefer home healthcare is also anticipated to contribute to segment growth. Moreover, smart pumps are now widely used because they include advanced features such as barcode technology, which aids in the verification of a patient's identity and prevents drug administration errors. The Anti-Infective Dominates the Worldwide Home Infusion Therapy Market In this report, Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, and Specialty Pharmaceuticals are the application segments of the market.
According to the analysis, the anti-infective market dominates the global home infusion therapy market, owing to the large number of procedures performed to administer antifungal and antibiotic drugs. It also helps to reduce patient exposure to other hospital-acquired infections (HAIs). Similarly, chemotherapy is expected to be one of the fastest-growing segments over the forecast period, owing to rising cancer incidences. Home chemotherapy pumps are compact and continuous pressure pumps that do not require a battery and can thus be used for a more extended period. Chemotherapy drugs can be dispensed at the appropriate infusion rate and amount with the help of these pumps. As a result, the demand for pressure pumps is expected to grow in the coming years. Regional Realms of Global Home Infusion Therapy Market
North America will dominate the market in the forecast period. Primarily, due to the regions increased R&D and rising adoption of new technology in infusion pumps. The regional market is being driven by the increasing need for long-term therapy for patients with certain conditions.
Furthermore, the development of alternative healthcare settings and home infusion services and the shift in appreciation from acute care to home care backdrops due to subordinate costs and increased patient mobility will propel the evolution of this market in the coming years. Over the forecast period, the Asia Pacific market is expected to grow at the fastest rate. This is due to increased patient awareness of the advantages of home infusion therapy over in-hospital procedures and the region's rising diabetes prevalence. The region's growing geriatric population and rise in chronic diseases are expected to fuel market growth even further. Key Topics Covered: 1. Introduction 2. Research & Methodology 3. Executive Summary 4. Market Dynamics 4.1 Growth Drivers 4.2 Challenges 5. Global Home Infusion Therapy Market 6. Market Share - Global Home Infusion Therapy Market 6.1 By Product 6.2 By Application 6.3 By Region 7. Product - Global Home Infusion Therapy Market 7.1 Infusion Pump 7.2 Intravenous Sets 7.3 IV Cannulas 7.4 Needleless Connectors 8. Application - Global Home Infusion Therapy Market 8.1 Anti-infective 8.2 Hydration Therapy 8.3 Chemotherapy 8.4 Enteral Nutrition 8.5 Parenteral Nutrition 8.6 Specialty Pharmaceuticals 8.7 Others 9. Region - Global Home Infusion Therapy Market 9.1 North America 9.2 Europe 9.3 Asia Pacific 9.4 Latin America 9.5 Middle East and America 10. Key Players 10.1 Overview 10.2 Recent Development 10.3 Revenue
Johnson & Johnson Services, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/k7ljyh
Global Home Infusion Therapy Market
Here is how the price structure of the S&P 500 could look like if the low in May 2022 marked the market bottom without the market capitulation based on Wyckoff trading method.
(Bloomberg) -- Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcastMost Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff to SellUkraine Latest: EU Leaders Talk to Putin; New Bid for SanctionsRussian Wins in Eastern Ukraine Spark Debate Over Course of WarThe European Central Bank’s debate over
After a long, dreary period of lingering close to zero, short-term yields are on the rise, so we asked advisors for their thoughts on the best places for clients to stash the cash portion of their portfolios. Richard Skae, vice chairman of Morgan Stanley Wealth Management Group, has died at age 65. Skae served as vice chair since 2017, and was credited as “absolutely instrumental to the success of our firm” by Andy Saperstein, co-president of Morgan Stanley and head of the wealth management division.
The dollar edged lower on Friday on its way to a second-straight weekly decline as traders pared expectations for U.S. Federal Reserve interest rate hikes and as improving inflation and consumer spending data eased recession fears. On a weekly basis, it was down 1.24%, following a 1.45% decline the previous week. The "Fed is fully priced and expectations for rate hikes later in the year may be subject to revision if the economy slows more quickly than expected," they said.
A growth-stock investor makes the case for a return to form in small-cap growth stocks. Plus, Broadcom and the chip shortage, Snap and internet advertising, and Thomas Peterffy on zero-commission trading.
Advance planning and a little discipline can keep you out of wedding debt.
One River’s initial application faced a delay in March.
Leesburg quantum computing software company Quantum Computing Inc. (NASDAQ: QUBT) is purchasing fellow quantum firm QPhoton Inc. in its first M&A deal. The acquisition will be paid for by a mixture of common stock, preferred stock and warrants and will represent in total approximately 49% of the total outstanding capital stock of QCI. Quantum Computing Inc., or QCI, began trading on the Nasdaq in July after three years on the over-the-counter market.
Yes, shares in Zoom Video soared during the coronavirus crisis. But what's the outlook for Zoom stock as in-person meetings rebound and the pandemic fades.
“Retiring early is a dream for many people,” said Landon Tan, a certified financial planner. “But those years of not working diminish your chance of a successful retirement more than almost any other metric we toggle when making financial plans.” When planning to retire early, those extra years need to be considered — at the forefront of retirement, but also in the back end if you live longer than anticipated.
Odds that some of the biggest Russian corporations will default have soared to 80%, according to pricing in credit-default swaps
Panelists at our inaugural cryptocurrency roundtable offer bold predictions for Bitcoin, stablecoins, blockchain, and more.
The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.
(Bloomberg) -- The US corruption and market manipulation cases against Glencore Plc include allegations about the conduct of two former executives who formed part of the inner circle of the trading house’s top management for over a decade -- and walked away as billionaires.Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff to SellUk
Trader reaction to the pivot at $1854.80 will determine the direction of the August Comex gold futures market early Monday.
Inflation and supply chain issues have cast a dark shadow over retail stocks. Never mind that people still need to eat even when prices go up, Target TGT stock has dropped 26.9% over the past month and Walmart WMT shares are down 16% during that same time period. Walmart and Target have leverage when it comes to the supply chain.
Hasbro's heated proxy war with activist investor Alta Fox Capital shows no sign of cooling down.
Reduced global fuel-making capacity is holding back supplies as drivers hit the road and demand recovers from the onset of the pandemic.
(Bloomberg) -- The European Union proposed banning seaborne oil from Russia while delaying restrictions on imports from a key pipeline in an effort to satisfy Hungarian objections and clinch an agreement on a stalled sanctions package that would target Moscow for its war in Ukraine. Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff
The major indexes snapped weekly losing streaks as a confirmed market rally added to gains Friday. How aggressive should you be?